Overexpression of MDM2 can lead to the suppression of p53 activity, which may result in insufficient cellular responses to DNA damage. This can contribute to the development of cancer by allowing cells with genetic mutations to survive and proliferate. In the context of toxicology, this is significant as it can influence the susceptibility of cells to mutagenic and carcinogenic agents.
